National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
84.06
-0.82 (-0.97%)
Mar 5, 2026, 4:00 PM EST - Market closed
National Health Investors Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for National Health Investors stock have an average target of 85.2, with a low estimate of 80 and a high estimate of 90. The average target predicts an increase of 1.36% from the current stock price of 84.06.
Analyst Consensus: Buy
* Price targets were last updated on Dec 16, 2025.
Analyst Ratings
The average analyst rating for National Health Investors stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $81 → $83 | Strong Buy | Maintains | $81 → $83 | -1.26% | Dec 16, 2025 |
| Keybanc | Keybanc | Buy Maintains $80 → $88 | Buy | Maintains | $80 → $88 | +4.69% | Dec 4, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $80 → $85 | Hold | Maintains | $80 → $85 | +1.12% | Nov 25, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $90 | Buy | Initiates | $90 | +7.07% | Oct 1, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $76 → $80 | Hold | Maintains | $76 → $80 | -4.83% | Aug 27, 2025 |
Financial Forecast
Revenue This Year
423.83M
from 379.29M
Increased by 11.74%
Revenue Next Year
462.07M
from 423.83M
Increased by 9.02%
EPS This Year
3.37
from 3.02
Increased by 11.53%
EPS Next Year
3.44
from 3.37
Increased by 2.25%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 453.4M | 506.3M | |||
| Avg | 423.8M | 462.1M | |||
| Low | 388.2M | 422.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 19.5% | 19.5% | |||
| Avg | 11.7% | 9.0% | |||
| Low | 2.3% | -0.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.68 | 3.68 | |
| Avg | 3.37 | 3.44 | |
| Low | 3.15 | 3.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.7% | 9.1% | |
| Avg | 11.5% | 2.2% | |
| Low | 4.2% | -3.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.